VasoHealthcare Holds Launch Summit 2010 In Greensboro, NC

Vasomedical Releases iPhone Application for EECP^® Therapy

Vasomedical Announces Reorganization of Its Board of Directors

Vaso Healthcare, a Subsidiary of Vasomedical, Inc. Signs Exclusive Sales Representative Agreement with GE Healthcare

Vasomedical Announces FDA 510(k) Clearance on the First Combined ECG Holter and Ambulatory Blood Pressure Monitoring System

More >>

Q: How Can EECP Therapy Help My Patients?
A: EECP therapy may reduce the need for medications, increase exercise tolerance and improve your patient’s quality of life.

Q: Is EECP Therapy a Safe Option for My Patients?
A: Yes, it’s completely non-invasive, thereby reducing the risk of complications associated with surgery. Complications as a result of treatment are typically minor and rare when compared to other treatments. Most people tolerate EECP therapy with no major discomfort, side effects or complications. Typical side effects include fatigue or muscle aches. A small number of people develop pressure sores, skin irritation or bruising from the cuff inflation.

Q: How Effective is EECP Therapy?
A: Scientific data shows that EECP therapy is 75-80% effective and the benefits are sustained for 3-5 years post treatment.

Q: How Can EECP Therapy Benefit My Practice?
A: By adding EECP therapy to your practice you can offer your “no option” patients an alternative and increase your revenue at the same time.

Q: How Can I Add an EECP Therapy System to My Practice?
A: There are several options, you can rent, lease, rent or lease to own, or own. Our sales professionals can help you choose the best option for you.

Q: What is the Difference Between EECP Therapy and ECP Therapy?
A: Vasomedical is committed to providing the safest, most effective, state-of-the-art external counterpulsation devices. With over 20 years experience in research, design, manufacturing and providing EECP therapy systems globally, you can be confident we will be here for you today, tomorrow and beyond.

Our systems are rigorously tested prior to entry into the market and are FDA cleared by 510(k) clearance letters, UL listed and CE marked. Vasomedical also elects to participate in ISO13485 to ensure you get the best possible product and patient outcomes.

Additionally, the safety and effectiveness of Vasomedical EECP therapy systems have been studied in various clinical trials, independent studies as well as registries which have been published in peer-reviewed journals, such as The Journal of the American College of Cardiology. ONLY Vasomedical EECP therapy systems have been scientifically validated through randomized, controlled clinical trials, peer-reviewed publications and registry data.  A complete list of published data about EECP therapy may be found on our EECP Therapy Bibliography.